QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

23,585 signal articles · 322 in last 24h · 112,405 total before filter · latest 59m ago
322last 24h
2135last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
AllMacro296Earnings1214M&A90Regulatory23Product13Analyst20
✕ clear all filtersticker: TDOCsentiment: bearishSentiment:bullishneutralbearishshow all (incl. clickbait)
🔎 Under the Radar: Teladoc Shares Tumble on Therapist Shortage
The Wall Street Journal13d agobearish
🔎 Under the Radar: Teladoc Shares Tumble on Therapist Shortage

Shares of Teladoc Health fell more than 25% Thursday after the telehealth company missed second-quarter revenue expectations and cut its full-year sales forecast. The pain is concentrated in BetterHelp, Teladoc's therapy and psychiatry platform, where revenue fell 12% to $212.6 million. Teladoc has pushed BetterHelp users toward insurance-covered therapy instead of cash-pay sessions.

Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead
24/7 Wall St.86d agobearish
Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the wreckage. But here’s what you should actually be watching. The Q1 2026 release on May 11, 2026 was a fracture. EPS came in ... Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead